SCHEMBL17762148

SCHEMBL17762148

COC(=O)[C@H]1CC(O)(C(F)(F)F)C[C@@H]1C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.33
CYP2C19 P33261 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRM8 O00222 1/20 0.33
GRM6 O15303 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP3A4 P08684 2/20 0.32
PPM1B O75688 1/20 0.32
PTPN1 P18031 1/20 0.32
PPP1CC P36873 1/20 0.32
ATM Q13315 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.31
HPSE Q9Y251 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17756085 0.78 GRM4 (0.38) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL23896104 0.78 CHRNB2 (0.37) KMT2ACYP3A4ATMKDM4E
SCHEMBL26656015 0.78 GRM4 (0.38) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL17756083 0.77 GRM4 (0.32) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL3240900 0.70 MMP2 (0.40) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL5431401 0.70 GRM4 (0.34) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL31082046 0.70 MMP2 (0.40) GRM4CYP2C19KMT2ACYP1A2CYP2D6
SCHEMBL16637758 0.69 KCNQ3 (0.37) CYP1A2PPM1BPTPN1PPP1CCTSHR
SCHEMBL16617896 0.69 KCNQ3 (0.37) CYP1A2PPM1BPTPN1PPP1CCTSHR
SCHEMBL15684140 0.69 CHRM2 (0.36) CYP1A2CYP2D6ALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2016-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF CYP3A7, CYP2C19, CYP3A5 GRM4 2373/4885CYP2C19 2/4885KMT2A 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.